Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ismail Abdulrashid"'
Publikováno v:
Infectious Disease Modelling, Vol 9, Iss 2, Pp 601-617 (2024)
Despite most COVID-19 infections being asymptomatic, mainland China had a high increase in symptomatic cases at the end of 2022. In this study, we examine China's sudden COVID-19 symptomatic surge using a conceptual SIR-based model. Our model conside
Externí odkaz:
https://doaj.org/article/d8ed57188965401988b0e1d894f101f8
Publikováno v:
Healthcare Analytics, Vol 5, Iss , Pp 100335- (2024)
Traditional randomized clinical trials are regarded as the gold standard for assessing the efficacy of chemotherapy. However, this procedure has drawbacks such as high cost, time consumption, and limited patient exploration of treatment regimens. We
Externí odkaz:
https://doaj.org/article/6202d3f6e1b84f77951ef8c6e7ef2eb5
Publikováno v:
Annals of Operations Research. 320:757-770
This note presents a novel chemotherapy protocol for physicians to treat cancer tumors. Mathematical modeling, analysis, and simulations are used to describe the detailed dynamics of tumor, effector-immune cells, lymphocyte population, and chemothera
Autor:
Ismail Abdulrashid, Xiaoying Han
Publikováno v:
Communications on Pure & Applied Analysis. 19:1875-1890
A nonautonomous mathematical model of chemotherapy cancer treatment with time-dependent infusion concentration of the chemotherapy agent is developed and studied. In particular, a mutual inhibition type model is adopted to describe the interactions b
Publikováno v:
Discrete & Continuous Dynamical Systems - B. 24:989-1005
A chemotherapy model for cancer treatment is studied, where the chemotherapy agent and cells are assumed to follow a predator-prey type relation. The time delays from the instant that the chemotherapy agent is injected to the instant that the treatme
Publikováno v:
ICM
In this paper, we investigate a nonautonomous model of chemotherapy cancer treatment with time-dependent infusion concentration of the chemotherapy agent. A predator-prey type model is adopted to describe the interactions between the chemotherapy age